Company
United StatesPublic company, NYSE: MRKMerck & Co Inc (NYSE: MRK), North Wales, PA – FDA Inspections
Inspection records and compliance data for Merck & Co Inc in North Wales, Pennsylvania. 5 FDA inspections on record, last inspected September 01, 2023. Publicly traded as NYSE: MRK.
Company Profile
This profile covers Merck & Co Inc based in North Wales, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 3
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected October 8, 2013. Last inspected September 1, 2023.
Most cited issue areas
- Failure to develop written procedures2 inspections
- Late submission of 15-day report2 inspections
- General responsibilities of sponsors1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 1, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1219020 |
| November 1, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1071196 |
| September 20, 2016 | VAI | Human Drugs · Bioresearch Monitoring | 988466 |
| April 12, 2016 | VAI | Human Drugs · Bioresearch Monitoring | 970042 |
| October 8, 2013 | VAI | Human Drugs · Bioresearch Monitoring | 849685 |
FDA documents
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Merck & Co Inc
Stock ticker
MRK
Exchange
NYSE
Share price
$146.99
Market cap
$362.4B
Price as of
November 13, 2026
FEI Number
3002721810
Address
351 N Sumneytown Pike, North Wales, Pennsylvania 19454, United States
Country
United States
ID: b31c98fd-1c55-4600-8977-5abbfb1991f5